European Journal of Surgical Oncology
Volume 33, Supplement 2 , Pages S88-S94, December 2007

Factors that influence treatment strategies in advanced colorectal cancer

  • C. Nesbitt
  • ,
  • R.J. Glendinning
  • ,
  • C. Byrne
  • ,
  • G.J. Poston

      Affiliations

    • Corresponding Author InformationCorresponding author: Department of Surgery, Liverpool Supra-Regional Hepatobiliary Centre, University Hospital Aintree, Lower Lane, Liverpool L9 7AL, UK. Tel.: +44 0151 529 8578; fax: +44 0151 529 8547.

Liverpool Supra-Regional Hepatobiliary Centre, University Hospital Aintree, Liverpool L9 7AL, UK

Accepted 26 September 2007.

Abstract 

This review focuses on the factors that now influence our treatment strategies designed to increase the pool of patients with colorectal liver metastases for whom curative treatment may be possible. These strategies include improved preoperative staging techniques, new standards for surgical resection, novel surgical strategies, the application of modern systemic chemotherapy in a neoadjuvant setting, an emerging role for ablative therapies and an emphasis on the collaborative, a reappraisal of staging advanced disease, multidisciplinary management, and defining the role of the patient in managing their disease. It is now clear that an aggressive multi-disciplinary approach to the management of this problem will lead to nearly one third of these patients being considered for treatment that even if not achieving complete cure, offers significant long-term survival.

Keywords: Colorectal cancer, Liver metastases, Staging, Liver surgery, Neoadjuvent treatment, Chemotherapy-associated steatohepatitis, Radiofrequency ablation, OncoSurge

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0748-7983(07)00555-0

doi:10.1016/j.ejso.2007.09.019

European Journal of Surgical Oncology
Volume 33, Supplement 2 , Pages S88-S94, December 2007